Generali Investments, Management Co LLC
Position in MRK — Merck & Co., Inc.
CIK 2043136
LJUBLJANA, 2A
Position in MRK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,548,989
+$2,353,544 QoQ
Shares Held
58,747
+36.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#851
of 3,769 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments, Management Co LLC holds $49,014,742 across 9 Drug Manufacturers - General names. MRK ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,220 | $12,258,175 | |
| 2 | JNJ |
Johnson & Johnson
|
32,881 | $8,350,787 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
58,747 | $7,548,989 | |
| 4 | ABBV |
AbbVie Inc.
|
29,767 | $7,490,567 | |
| 5 | PFE |
Pfizer Inc
|
189,601 | $4,565,592 | |
| 6 | AMGN |
Amgen Inc
|
9,966 | $3,608,887 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,496 | $2,589,464 | |
| 8 | BIIB |
Biogen Inc.
|
7,437 | $1,606,838 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,548,989 | 58,747 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $5,195,445 | 43,191 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $5,174,581 | 49,160 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,121,692 | 37,194 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,000,610 | 25,273 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,737,933 | 19,362 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,029,066 | 30,449 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||